# A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer

> **NCT03167112** · PHASE2 · UNKNOWN · sponsor: **Petr Kavan** · enrollment: 20 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan
- **DRUG:** Leucovorin
- **DRUG:** Fluorouracil

## Key facts

- **NCT ID:** NCT03167112
- **Lead sponsor:** Petr Kavan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-03
- **Primary completion:** 2018-03
- **Final completion:** 2018-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03167112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03167112, "A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03167112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*